Literature DB >> 29453193

Risks of reformulation: French patients complain after Merck modifies levothyroxine pills.

Barbara Casassus1.   

Abstract

Entities:  

Year:  2018        PMID： 29453193     DOI： 10.1136/bmj.k714

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".

Authors:  Cedric Bousquet; Bissan Audeh; Florelle Bellet; Agnès Lillo-Le Louët
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

2.  Factors influencing the use of the "not for generic substitution" mention for prescriptions in primary care: a survey with general practitioners.

Authors:  Virgil Beauvais; Annabelle Marque; Guillaume Ferté; Jan Chrusciel; Julie Souille; Pierre Nazeyrollas; Stéphane Sanchez
Journal:  BMC Health Serv Res       Date:  2018-11-12       Impact factor: 2.655

Review 3.  Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.

Authors:  Salvatore Benvenga; Allan Carlé
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

4.  Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase®.

Authors:  Ulrich Vogel; John van Stekelenborg; Brian Dreyfus; Anju Garg; Marian Habib; Romana Hosain; Antoni Wisniewski
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

5.  Identification of Primary Medication Concerns Regarding Thyroid Hormone Replacement Therapy From Online Patient Medication Reviews: Text Mining of Social Network Data.

Authors:  So Hyun Park; Song Hee Hong
Journal:  J Med Internet Res       Date:  2018-10-24       Impact factor: 5.428
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.